Intravenous Immunoglobulin Market to Expand Strongly Driven by Rising Autoimmune Disorders and Advancements in Plasma-Derived Therapies

https://growthmarketreports.co....m/report/intravenous

The Intravenous Immunoglobulin Market refers to the global industry focused on the production and distribution of immunoglobulin therapies administered intravenously to treat immune deficiencies, autoimmune diseases, and inflammatory conditions. IVIG is a plasma-derived biological product containing antibodies that help strengthen immune response in patients with weakened or dysfunctional immune systems.

Intravenous Immunoglobulin Market Research Report 2033
growthmarketreports.com

Intravenous Immunoglobulin Market Research Report 2033

According to our latest research, the global intravenous immunoglobulin (IVIG) market size reached USD 15.7 billion in 2024, reflecting steady expansion driven by rising prevalence of immunodeficiency disorders and increasing adoption of advanced th